TSE:TRL - Trilogy International Partners Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$2.70 +0.21 (+8.43 %) (As of 05/22/2019 03:23 PM ET)Previous CloseC$2.50Today's RangeC$2.49 - C$2.7752-Week RangeC$1.22 - C$4.80Volume63,400 shsAverage Volume40,864 shsMarket CapitalizationC$156.40 millionP/E RatioN/ADividend Yield0.80%BetaN/A ProfileAnalyst RatingsChartDividendEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communication services in Bolivia and New Zealand. The company's communications services include local, international long distance, and roaming services for customers and international visitors roaming on their networks. It also provides fixed broadband communications services to business and residential customers. The company serves 15.9 million customers. Trilogy International Partners Inc. is headquartered in Bellevue, Washington. Receive TRL News and Ratings via Email Sign-up to receive the latest news and ratings for TRL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolTSE:TRL Previous SymbolTSE:AQX.A CUSIPN/A CIKN/A Webhttp://www.trilogy-international.co.../ Phone+1-425-4585900Debt Debt-to-Equity RatioN/A Current Ratio1.08 Quick Ratio0.81Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-39.27 Sales & Book Value Annual SalesC$783.23 million Price / Sales0.20 Cash FlowC$2.33 per share Price / Cash Flow1.16 Book ValueC($1.28) per share Price / Book-2.11Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,821 Outstanding Shares57,925,000Market CapC$156.40 million Next Earnings Date8/14/2019 (Estimated) OptionableNot Optionable Trilogy International Partners (TSE:TRL) Frequently Asked Questions What is Trilogy International Partners' stock symbol? Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL." How often does Trilogy International Partners pay dividends? What is the dividend yield for Trilogy International Partners? Trilogy International Partners announced an annual dividend on Monday, April 15th. Stockholders of record on Monday, May 6th will be given a dividend of 0.02 per share on Monday, May 6th. This represents a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, April 15th. View Trilogy International Partners' Dividend History. How were Trilogy International Partners' earnings last quarter? Trilogy International Partners Inc (TSE:TRL) released its earnings results on Wednesday, March, 27th. The specialty pharmaceutical company reported ($0.09) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.10. The specialty pharmaceutical company earned $273.61 million during the quarter, compared to the consensus estimate of $265.83 million. View Trilogy International Partners' Earnings History. When is Trilogy International Partners' next earnings date? Trilogy International Partners is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Trilogy International Partners. What price target have analysts set for TRL? 2 brokerages have issued 1-year target prices for Trilogy International Partners' shares. Their predictions range from C$3.50 to C$3.50. On average, they expect Trilogy International Partners' stock price to reach C$3.50 in the next twelve months. This suggests a possible upside of 29.6% from the stock's current price. View Analyst Price Targets for Trilogy International Partners. What is the consensus analysts' recommendation for Trilogy International Partners? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Trilogy International Partners. Has Trilogy International Partners been receiving favorable news coverage? News headlines about TRL stock have trended somewhat positive on Wednesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trilogy International Partners earned a news impact score of 0.6 on InfoTrie's scale. They also gave headlines about the specialty pharmaceutical company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. Who are some of Trilogy International Partners' key competitors? Some companies that are related to Trilogy International Partners include Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS), Futura Medical (FUM), Cathay International (CTI), Patrys (PAB), Avivagen (VIV), Recce Pharmaceuticals (RCE), Antisense Therapeutics (ANP) and NanoViricides (NNVC). What other stocks do shareholders of Trilogy International Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Millicom International Cellular (MIICF), Oncolytics Biotech (ONCYF), Emera (EMA), Glacier Bancorp (GBCI), Fibrocell Science (FCSC), CytomX Therapeutics (CTMX), CSX (CSX), Check Cap (CHEK) and Cboe Global Markets (CBOE). Who are Trilogy International Partners' key executives? Trilogy International Partners' management team includes the folowing people: Mr. John William Stanton, Chairman (Age 64)Mr. Bradley Jay Horwitz, Co-Founder, Pres, CEO & Non-Independent Director (Age 63)Ms. Theresa E. Gillespie, Co-Founder & Non-Independent Director (Age 66)Mr. Erik Mickels, Sr. VP & CFOMr. Scott Morris, Sr. VP, Gen. Counsel & Corp. Sec. How do I buy shares of Trilogy International Partners? Shares of TRL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Trilogy International Partners' stock price today? One share of TRL stock can currently be purchased for approximately C$2.70. How big of a company is Trilogy International Partners? Trilogy International Partners has a market capitalization of C$156.40 million and generates C$783.23 million in revenue each year. Trilogy International Partners employs 1,821 workers across the globe. What is Trilogy International Partners' official website? The official website for Trilogy International Partners is http://www.trilogy-international.co.../. How can I contact Trilogy International Partners? Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900. MarketBeat Community Rating for Trilogy International Partners (TSE TRL)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 177 (Vote Outperform)Underperform Votes: 116 (Vote Underperform)Total Votes: 293MarketBeat's community ratings are surveys of what our community members think about Trilogy International Partners and other stocks. Vote "Outperform" if you believe TRL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: What is the Gross Domestic Product (GDP)? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.